Künzle Venenbeschwerden Pinus Pygenol

Künzle Venenbeschwerden Pinus Pygenol is a medicine authorised by Swissmedic under authorisation number 49969. The authorisation holder is Tentan AG. The medicinal product code is Herbal medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 17 October 1991 and the authorisation is valid without a time limit. ATC code C05CX places the medicine in the group Vasoprotectives.

  • Dispensing category D
  • Authorisation number 49969
  • ATC C05CX
  • Herbal medicines
Authorisation data
Authorisation number49969
NameKünzle Venenbeschwerden Pinus Pygenol
Full nameKünzle Venenbeschwerden Pinus Pygenol, überzogene Tabletten
Authorisation holderTentan AG
Medicinal product codeHerbal medicines
Dispensing categoryD · No prescription, with advice
ATC codeC05CX
First authorisation17 October 1991
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Künzle Venenbeschwerden Pinus Pygenol, überzogene TablettenD17 October 1991

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
140Tablette(n)C05CX02.08.1.D
2120Tablette(n)C05CX02.08.1.D

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Künzle Venenbeschwerden Pinus Pygenol authorised in Switzerland?

Yes. Künzle Venenbeschwerden Pinus Pygenol is authorised by Swissmedic under authorisation number 49969, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Künzle Venenbeschwerden Pinus Pygenol have?

Künzle Venenbeschwerden Pinus Pygenol is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.

Who is the authorisation holder of Künzle Venenbeschwerden Pinus Pygenol?

The authorisation holder is Tentan AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com